Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Although the percentage of patients using statins did not differ significantly between the two groups, the percentage tended to be lower in ALT responders than in ALT non-responders
The Phase 2 data, while exceptional, is preliminary by regulatory standards
Since its inception more than 50 years ago, BrightFocus and its flagship research programsAlzheimers Disease Research, Macular Degeneration Research, and National Glaucoma Researchhas awarded more than $330 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools
Imhof ML, J
US$ 20.25
US$ 22.90
US$ 26.43
US$ 29.19
US$ 29.56
US$ 22.85
US$ 25.93
